The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M 4 muscarinic acetylcholine receptor knockout mice
Open accessAbstract
Muscarinic acetylcholine receptors (M 1 –M 5 ) regulate many key functions of the central and peripheral nervous system. Primarily because of the lack of receptor subtype-selective ligands, the precise physiological roles of the individual muscarinic receptor subtypes remain to be elucidated. Interestingly, the M 4 receptor subtype is expressed abundantly in the striatum and various other forebrain regions. To study its potential role in the regulation of locomotor activity and other central functions, we used gene-targeting technology to create mice that lack functional M 4 receptors. Pharmacologic analysis of M 4 receptor-deficient mice indicated that M 4 receptors are not required for muscarinic receptor-mediated analgesia, tremor, hypothermia, and salivation. Strikingly, M 4 receptor-deficient mice showed an increase in basal locomotor activity and greatly enhanced locomotor responses (as compared with their wild-type littermates) after activation of D1 dopamine receptors. These results indicate that M 4 receptors exert inhibitory control on D1 receptor-mediated locomotor stimulation, probably at the level of striatal projection neurons where the two receptors are coexpressed at high levels. Our findings offer new perspectives for the treatment of Parkinson’s disease and other movement disorders that are characterized by an imbalance between muscarinic cholinergic and dopaminergic neurotransmission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R. (1990) · Science · doi:10.1126/science.2147780 · Cited by 2,967
Muscarinic Receptors—Characterization, coupling and function
Caulfield, M. P. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90027-b · Cited by 1,277
Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone Growth
Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A., & Leder, P. (1996) · Cell · doi:10.1016/s0092-8674(00)81069-7 · Cited by 1,070
Self-citationMolecular biology of dopamine receptors
Sibley, D. R., & Monsma, F. J. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90025-2 · Cited by 988
Levey, A., Kitt, C., Simonds, W., Price, D., & Brann, M. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-10-03218.1991 · Cited by 918
Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype?
Gerlai, R. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)20020-7 · Cited by 881
Antagonist binding profiles of five cloned human muscarinic receptor subtypes.
Dörje, F., Wess, J., Lambrecht, G., Tacke, R., Mutschler, E., & Brann, M. R. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23208-6 · Cited by 610
Self-citationThe Pharmacological Basis of Therapeutics.
Goodman, L., & Gilman, A. (1941) · Anesthesia & Analgesia · doi:10.1213/00000539-194101000-00064 · Cited by 599
Molecular Biology of Muscarinic Acetylcholine Receptors
Wess, J. (1996) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v10.i1.40 · Cited by 488
Self-citationXu, M., Moratalla, R., Gold, L. H., Hiroi, N., Koob, G. F., Graybiel, A. M., & Tonegawa, S. (1994) · Cell · doi:10.1016/0092-8674(94)90557-6 · Cited by 484
Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia.
Weiner, D. M., Levey, A. I., & Brann, M. R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.7050 · Cited by 480
Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene.
Le Moine, C., Normand, E., & Bloch, B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4205 · Cited by 472
Dopamine receptor gene expression by enkephalin neurons in rat forebrain.
Le Moine, C., Normand, E., Guitteny, A. F., Fouque, B., Teoule, R., & Bloch, B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.230 · Cited by 470
Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions
Di Chiara, G., Morelli, M., & Consolo, S. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90005-1 · Cited by 467
Levey, A. I. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90300-r · Cited by 448
Kelly, M. A., Rubinstein, M., Phillips, T. J., Lessov, C. N., Burkhart-Kasch, S., Zhang, G., Bunzow, J. R., Fang, Y., Gerhardt, G. A., Grandy, D. K., et al. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03470.1998 · Cited by 447
Hersch, S., Gutekunst, C., Rees, H., Heilman, C., & Levey, A. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-05-03351.1994 · Cited by 404
Hamilton, S. E., Loose, M. D., Qi, M., Levey, A. I., Hille, B., McKnight, G. S., Idzerda, R. L., & Nathanson, N. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13311 · Cited by 366
Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice
Gomeza, J., Shannon, H., Kostenis, E., Felder, C., Zhang, L., Brodkin, J., Grinberg, A., Sheng, H., & Wess, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1692 · Cited by 348
Self-citationPhenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes
Bernard, V, Normand, E., & Bloch, B. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-09-03591.1992 · Cited by 327
Gerfen, C., Keefe, K., & Gauda, E. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-12-08167.1995 · Cited by 283
Yasuda, R. P., Ciesla, W., Flores, L. R., Wall, S. J., Li, M., Satkus, S. A., Weisstein, J. S., Spagnola, B. V., & Wolfe, B. B. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13594-3 · Cited by 217
Brain neurotransmitter changes in Parkinson's disease
Hornykiewicz, O. (1981) · Movement Disorders · doi:10.1016/b978-0-407-02295-9.50009-6 · Cited by 159
Iwamoto, E. T., & Marion, L. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38297-2 · Cited by 145
Starr, B. S., & Starr, M. S. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90168-1 · Cited by 142
Cabib, S., Castellano, C., Cestari, V., Filibeck, U., & Puglisi‐Allegra, S. (1991) · Psychopharmacology · doi:10.1007/bf02244427 · Cited by 129
Sacaan, A. I., Bymaster, F. P., & Schoepp, D. D. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08897.x · Cited by 115
Self-citationLethal α–thalassaemia created by gene targeting in mice and its genetic rescue
Pászty, C., Mohandas, N., Stevens, M. E., Loring, J. F., Liebhaber, S. A., Brion, C. M., & Rubin, E. M. (1995) · Nature Genetics · doi:10.1038/ng0995-33 · Cited by 82
Cholinergic mechanisms in pain and analgesia.
Hartvig, P., Gillberg, P.-G., Gordh, T., & Post, C. (1989) · PubMed · Cited by 79
Development of Muscarinic Analgesics Derived from Epibatidine: Role of the M4 Receptor Subtype
Ellis, J. L., Harman, D., González‐Gallego, J., Spera, M. L., Liu, R., Shen, T. Y., Wypij, D. M., & Zuo, F. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38067-x · Cited by 71
Vilaró, M. T., Mengod, G., & Palacios, J. M. (1993) · Progress in brain research · doi:10.1016/s0079-6123(08)62385-7 · Cited by 63
Antinociception opioids and the cholinergic system
Green, P. G., & Kitchen, I. (1986) · Progress in Neurobiology · doi:10.1016/0301-0082(86)90002-x · Cited by 53
Butylthio[2.2.2] (NNC 11–1053/LY297802): An Orally Active Muscarinic Agonist Analgesic
Swedberg, M. D. B., Sheardown, M. J., Sauerberg, P., Olesen, P. H., Suzdak, P. D., Hansen, K. T., Bymaster, F. P., Ward, J. S., Mitch, C. H., Calligaro, D. O., et al. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36644-3 · Cited by 31
Self-citationShannon, H. E., Womer, D. E., Bymaster, F. P., Calligaro, D. O., DeLapp, N. C., Mitch, C. H., Ward, J. S., Whitesitt, C. A., Swedberg, M. D. B., Sheardown, M. J., et al. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00036-2 · Cited by 17
Self-citationFarrell, C. B., Lawlor, M., Dunne, A., & O’Boyle, K. M. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65031124.x · Cited by 5
Cited by
Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development
Wess, J., Eglen, R. M., & Gautam, D. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2379 · Cited by 637
Self-citationSelective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia
Shekhar, A., Potter, W. Z., Lightfoot, J., Lienemann, J., Dubé, S., Mallinckrodt, C., Bymaster, F. P., McKinzie, D. L., & Felder, C. C. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.06091591 · Cited by 560
Self-citationMatsui, M., Motomura, D., Karasawa, H., Fujikawa, T., Jiang, J., Komiya, Y., Takahashi, S.-I., & Taketo, M. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9579 · Cited by 450
Muscarinic acetylcholine receptors as CNS drug targets
Langmead, C. J., Watson, J., & Reavill, C. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.09.009 · Cited by 419
Muscarinic Acetylcholine Receptor Knockout Mice: Novel Phenotypes and Clinical Implications
Wess, J. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121622 · Cited by 380
Self-citation
Metadata
- Authors
- Gomeza, J., Zhang, L., Kostenis, E., Felder, C., Bymaster, F., Brodkin, J., Shannon, H., Xia, B., Deng, C.-X., & Wess, J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-08-31
- Volume
- 96
- Issue
- 18
- Pages
- 10483-10488
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2068538092
- Cited by
- 322
- References
- 35
- FWCI
- 4.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.